Can the Future of ID Escape the Inertial Dogma of Its Past? The Exemplars of Shorter Is Better and Oral Is the New IV
Kusha Davar(University of Southern California), Brad Spellberg(Harbor–UCLA Medical Center), Emily G. McDonald(McGill University Health Centre), Fernándo Domínguez(Hospital Universitario Puerta de Hierro Majadahonda), Matthew C. Phillips(Harvard University), Todd C. Lee(McGill University Health Centre), Parham Sendi(University of Bern), Rachael Lee(University of Alabama at Birmingham), Bassam Ghanem(King Abdulaziz Medical City), Devin Clark(University of Southern California), Robert M. Centor(Birmingham VA Medical Center)
Cited by 73
Related Papers
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
|New England Journal of Medicine|2020|1.4k
Pathogenesis of Mucormycosis
|Clinical Infectious Diseases|2012|806
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19
|Annals of Internal Medicine|2020|548
Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies
|Journal of the American College of Cardiology|2016|472
Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths
|European Heart Journal|2017|373